Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Corbett

Showing results (341-350 of 361) with videos related to

Pageof 37
Sort By:
HIV Medicine|February 26, 2013
Pharmacokinetics of two common antiretroviral regimens in older HIV-infected patients: a pilot studyJ B Dumond, J L Adams, H M A Prince, et al.
Pharmacogenomics|November 25, 2011
Exploration of CYP450 and drug transporter genotypes and correlations with nevirapine exposure in MalawiansKevin C Brown, Mina C Hosseinipour, Janelle M Hoskins, et al.
RNA (New York, N.Y.)|June 24, 2021
A budding yeast model for human disease mutations in the <i>EXOSC2</i> cap subunit of the RNA exosome complexMaria C Sterrett, Liz Enyenihi, Sara W Leung, et al.
Journal of Medicinal Chemistry|September 11, 1998
Synthesis and antitumor activity of 4-aminomethylthioxanthenone and 5-aminomethylbenzothiopyranoindazole derivativesR B Perni, M P Wentland, J I Huang, et al.
Biorxiv : the Preprint Server for Biology|October 24, 2023
Histone H3 E50K mutation confers oncogenic activity and supports an EMT phenotypeKirti Sad, Celina Y Jones, Dorelle V Fawwal, et al.
Investigational New Drugs|December 16, 1998
Preclinical antitumor efficacy of analogs of XK469: sodium-(2-[4-(7-chloro-2-quinoxalinyloxy)phenoxy]propionateT H Corbett, P LoRusso, L Demchick, et al.
Investigational New Drugs|November 11, 1999
Preclinical efficacy of thioxanthone SR271425 against transplanted solid tumors of mouse and human originT H Corbett, C Panchapor, L Polin, et al.
Antiviral Therapy|January 28, 2014
Antiretroviral pharmacokinetics in mothers and breastfeeding infants from 6 to 24 weeks post-partum: results of the BAN StudyAmanda H Corbett, Dumbani Kayira, Nicole R White, et al.
Cell Reports|August 10, 2017
The Conserved, Disease-Associated RNA Binding Protein dNab2 Interacts with the Fragile X Protein Ortholog in Drosophila NeuronsRick S Bienkowski, Ayan Banerjee, J Christopher Rounds, et al.
Journal of Experimental Therapeutics & Oncology|March 1, 1996
Preclinical anticancer activity of cryptophycin-8T H Corbett, F A Valeriote, L Demchik, et al.
Pageof 37

Showing results (341-350 of 361) with videos related to

Sort By:
Pageof 37
HIV Medicine|February 26, 2013
Pharmacokinetics of two common antiretroviral regimens in older HIV-infected patients: a pilot studyJ B Dumond, J L Adams, H M A Prince, et al.
Pharmacogenomics|November 25, 2011
Exploration of CYP450 and drug transporter genotypes and correlations with nevirapine exposure in MalawiansKevin C Brown, Mina C Hosseinipour, Janelle M Hoskins, et al.
RNA (New York, N.Y.)|June 24, 2021
A budding yeast model for human disease mutations in the <i>EXOSC2</i> cap subunit of the RNA exosome complexMaria C Sterrett, Liz Enyenihi, Sara W Leung, et al.
Journal of Medicinal Chemistry|September 11, 1998
Synthesis and antitumor activity of 4-aminomethylthioxanthenone and 5-aminomethylbenzothiopyranoindazole derivativesR B Perni, M P Wentland, J I Huang, et al.
Biorxiv : the Preprint Server for Biology|October 24, 2023
Histone H3 E50K mutation confers oncogenic activity and supports an EMT phenotypeKirti Sad, Celina Y Jones, Dorelle V Fawwal, et al.
Investigational New Drugs|December 16, 1998
Preclinical antitumor efficacy of analogs of XK469: sodium-(2-[4-(7-chloro-2-quinoxalinyloxy)phenoxy]propionateT H Corbett, P LoRusso, L Demchick, et al.
Investigational New Drugs|November 11, 1999
Preclinical efficacy of thioxanthone SR271425 against transplanted solid tumors of mouse and human originT H Corbett, C Panchapor, L Polin, et al.
Antiviral Therapy|January 28, 2014
Antiretroviral pharmacokinetics in mothers and breastfeeding infants from 6 to 24 weeks post-partum: results of the BAN StudyAmanda H Corbett, Dumbani Kayira, Nicole R White, et al.
Cell Reports|August 10, 2017
The Conserved, Disease-Associated RNA Binding Protein dNab2 Interacts with the Fragile X Protein Ortholog in Drosophila NeuronsRick S Bienkowski, Ayan Banerjee, J Christopher Rounds, et al.
Journal of Experimental Therapeutics & Oncology|March 1, 1996
Preclinical anticancer activity of cryptophycin-8T H Corbett, F A Valeriote, L Demchik, et al.
Pageof 37